Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Progyny stock

PGNY
US74340E1038
A2PT5Q

Price

20.62
Today +/-
-0.13
Today %
-0.63 %

Progyny stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Progyny stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Progyny stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Progyny stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Progyny's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Progyny Stock Price History

DateProgyny Price
1/16/202520.62 undefined
1/15/202520.75 undefined
1/14/202520.04 undefined
1/13/202520.30 undefined
1/10/202518.76 undefined
1/8/202518.25 undefined
1/7/202517.48 undefined
1/6/202517.43 undefined
1/3/202517.60 undefined
1/2/202517.73 undefined
12/31/202417.25 undefined
12/30/202416.93 undefined
12/27/202416.90 undefined
12/26/202414.71 undefined
12/24/202414.53 undefined
12/23/202414.49 undefined
12/20/202414.34 undefined
12/19/202414.19 undefined

Progyny Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Progyny, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Progyny from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Progyny’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Progyny. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Progyny’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Progyny’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Progyny’s growth potential.

Progyny Revenue, EBIT and net profit per share

DateProgyny RevenueProgyny EBITProgyny Net Income
2029e1.86 B undefined328.24 M undefined238.85 M undefined
2028e1.68 B undefined292.54 M undefined206.28 M undefined
2027e1.48 B undefined256.43 M undefined186.15 M undefined
2026e1.32 B undefined192.65 M undefined77.38 M undefined
2025e1.18 B undefined169.13 M undefined52.62 M undefined
2024e1.17 B undefined171.28 M undefined47.63 M undefined
20231.09 B undefined62.18 M undefined62.04 M undefined
2022786.9 M undefined23.3 M undefined30.4 M undefined
2021500.6 M undefined32.3 M undefined65.8 M undefined
2020344.9 M undefined9.2 M undefined46.5 M undefined
2019229.7 M undefined12.1 M undefined-8.6 M undefined
2018105.4 M undefined-3.5 M undefined-5.5 M undefined
201748.6 M undefined-11 M undefined-13.5 M undefined

Progyny Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20172018201920202021202220232024e2025e2026e2027e2028e2029e
0.050.110.230.340.50.791.091.171.181.321.481.681.86
-118.75118.1050.2245.3557.2038.427.261.1111.5312.4613.7210.64
14.5818.1019.6520.3522.4021.2521.8820.3920.1718.0916.0814.1412.78
7194570112167238000000
-13-5-846653062475277186206238
--61.5460.00-675.0041.30-53.85106.67-24.1910.6448.08141.5610.7515.53
82.282.282.299.1100.4100100.67000000
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Progyny Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Progyny is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2017201820192020202120222023
             
4.70.180.4109.3119.4189.3371.09
11.423.347.175.7134.6240.1241.87
0000000
0000000
0.71.155.34.64.527.45
16.824.5132.5190.3258.6433.9640.41
0.60.83.112.112.815.327.82
0000000
0000000
5.33.92.41.20.60.10
11.911.911.911.911.911.911.88
0.40.30.738.574.281.976.52
18.216.918.163.799.5109.2116.21
3541.4150.6254358.1543.1756.62
             
108.3106.200000.01
6.910.6228.8236.1255.3349.5461.64
-104.6-104.9-113.5-68.2-2.427.989.97
0000-0.10.52.82
0000000
10.611.9115.3167.9252.8377.9554.44
5.115.619.443.561.4109.3125.43
7.19.414.930.435.343.859.34
251.93.82.26.51.18
030000000
3.6000000
17.830.336.277.798.9159.6185.95
1.6000000
0000000
4.9009.27.46.517.24
6.5009.27.46.517.24
24.330.336.286.9106.3166.1203.19
34.942.2151.5254.8359.1544757.63
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Progyny provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Progyny's financial health and stability.

Assets

Progyny's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Progyny must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Progyny after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Progyny's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2017201820192020202120222023
-120-846653062
1121112
0-10-37-33-63
-10-197-51-59-17
44293177215260
0000000
0000006
-92-1362680188
00-2-1-2-3-3
01-2-408-43-200
020-3810-40-196
0000000
-3-500000
15-3842234
11-884-6-13-7-11
----8.00-16.00-10.00-15.00
0000000
1-480-102128-22
-10.081.69-4.4935.1623.9177.16185.17
0000000

Progyny stock margins

The Progyny margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Progyny. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Progyny.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Progyny's sales revenue. A higher gross margin percentage indicates that the Progyny retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Progyny's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Progyny's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Progyny's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Progyny. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Progyny's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Progyny Margin History

Progyny Gross marginProgyny Profit marginProgyny EBIT marginProgyny Profit margin
2029e21.94 %17.63 %12.83 %
2028e21.94 %17.38 %12.26 %
2027e21.94 %17.33 %12.58 %
2026e21.94 %14.64 %5.88 %
2025e21.94 %14.33 %4.46 %
2024e21.94 %14.68 %4.08 %
202321.94 %5.71 %5.7 %
202221.26 %2.96 %3.86 %
202122.39 %6.45 %13.14 %
202020.32 %2.67 %13.48 %
201919.81 %5.27 %-3.74 %
201818.41 %-3.32 %-5.22 %
201715.23 %-22.63 %-27.78 %

Progyny Stock Sales Revenue, EBIT, Earnings per Share

The Progyny earnings per share therefore indicates how much revenue Progyny has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Progyny earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Progyny's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Progyny’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Progyny's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Progyny Revenue, EBIT and net profit per share

DateProgyny Sales per ShareProgyny EBIT per shareProgyny Earnings per Share
2029e21.87 undefined0 undefined2.81 undefined
2028e19.77 undefined0 undefined2.42 undefined
2027e17.38 undefined0 undefined2.19 undefined
2026e15.46 undefined0 undefined0.91 undefined
2025e13.86 undefined0 undefined0.62 undefined
2024e13.71 undefined0 undefined0.56 undefined
202310.81 undefined0.62 undefined0.62 undefined
20227.87 undefined0.23 undefined0.3 undefined
20214.99 undefined0.32 undefined0.66 undefined
20203.48 undefined0.09 undefined0.47 undefined
20192.79 undefined0.15 undefined-0.1 undefined
20181.28 undefined-0.04 undefined-0.07 undefined
20170.59 undefined-0.13 undefined-0.16 undefined

Progyny business model

Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny is one of the most popular companies on Eulerpool.com.

Progyny SWOT Analysis

Strengths

Progyny Inc has established itself as a leader in the fertility benefits management industry, providing comprehensive solutions for employers and patients alike. The company's strengths lie in:

  • Advanced technology platform that streamlines the fertility treatment process
  • Strong network of top-tier fertility clinics and specialists
  • Patent-protected services and proprietary fertility medication discounts
  • Positive reputation and high customer satisfaction

Weaknesses

While Progyny Inc has several strengths, there are some areas where the company can improve:

  • Relatively high costs associated with fertility treatments may limit market reach
  • Dependency on employer-funded contracts, which can be affected by economic fluctuations
  • Limited international expansion, focusing primarily on the United States market

Opportunities

Progyny Inc can capitalize on various opportunities in the fertility benefits management sector:

  • Increasing awareness and acceptance of fertility treatments, fueling market growth
  • Expansion into international markets with high demand for fertility services
  • Potential partnerships with insurance providers to broaden coverage options
  • Advancements in reproductive technologies, opening up new treatment possibilities

Threats

As with any business, Progyny Inc faces certain threats that could impact its operations:

  • Competition from other fertility benefits management companies, leading to potential market saturation
  • Changes in government regulations and healthcare policies that may affect reimbursement and coverage
  • Economic downturns impacting employer-based funding for fertility treatments

Progyny Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Progyny Revenue by Segment

Segmente20232022
Fertility benefit services revenue676.3 M USD510.15 M USD
Pharmacy benefit services revenue412.3 M USD276.77 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Progyny Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Progyny historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Progyny shares outstanding

The number of shares was Progyny in 2024 — This indicates how many shares 100.672 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Progyny earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Progyny's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Progyny’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Progyny's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Progyny.

Progyny latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.14 0.11  (-19.12 %)2024 Q3
6/30/20240.17 0.17  (-1.62 %)2024 Q2
3/31/20240.13 0.17  (26.02 %)2024 Q1
12/31/20230.11 0.13  (19.16 %)2023 Q4
9/30/20230.12 0.16  (33.89 %)2023 Q3
6/30/20230.11 0.15  (40.98 %)2023 Q2
3/31/20230.08 0.18  (137.47 %)2023 Q1
12/31/20220.01 0.03  (152.1 %)2022 Q4
9/30/20220.05 0.13  (170.27 %)2022 Q3
6/30/20220.05 0.09  (96.08 %)2022 Q2
1
2
3

Eulerpool ESG Scorecard© for the Progyny stock

Eulerpool World ESG Rating (EESG©)

32/ 100

🌱 Environment

13

👫 Social

68

🏛️ Governance

15

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Progyny shareholders

%
Name
Stocks
Change
Date
11.65585 % BlackRock Institutional Trust Company, N.A.9,924,959367,3336/30/2024
9.67033 % The Vanguard Group, Inc.8,234,286-59,1816/30/2024
7.74829 % TPG Capital, L.P.6,597,67206/30/2024
6.27826 % Seidenberg (Beth C)5,345,9377,2065/23/2024
5.95962 % Kleiner, Perkins, Caufield & Byers5,074,615012/31/2023
4.02184 % ClearBridge Investments, LLC3,424,601-72,4336/30/2024
3.49829 % State Street Global Advisors (US)2,978,79379,7176/30/2024
3.11392 % JP Morgan Asset Management2,651,503-467,1586/30/2024
2.62520 % Fred Alger Management, LLC2,235,354-121,1196/30/2024
2.38001 % Geode Capital Management, L.L.C.2,026,579121,4156/30/2024
1
2
3
4
5
...
10

Progyny Executives and Management Board

Mr. Peter Anevski

(55)
Progyny Chief Executive Officer, Director (since 2017)
Compensation 68.58 M

Mr. David Schlanger

(63)
Progyny Executive Chairman of the Board (since 2017)
Compensation 17.35 M

Mr. Michael Sturmer

(46)
Progyny President
Compensation 7.94 M

Mr. Mark Livingston

(57)
Progyny Chief Financial Officer
Compensation 6.03 M

Ms. Allison Swartz

(34)
Progyny Executive Vice President, General Counsel, Company Secretary
Compensation 5.89 M
1
2
3
4

Most common questions regarding Progyny

What values and corporate philosophy does Progyny represent?

Progyny Inc represents a strong commitment to reproductive health and family building. The company's corporate philosophy revolves around providing comprehensive fertility benefits and exceptional patient care. Progyny Inc strongly believes in empowering individuals and couples to make informed decisions about their fertility journeys. Their values include compassion, integrity, innovation, and a dedication to improving the lives of individuals struggling with infertility. Progyny Inc's mission is to ensure cost-effective, high-quality fertility solutions and support, helping individuals and families achieve their dream of having a baby.

In which countries and regions is Progyny primarily present?

Progyny Inc is primarily present in the United States.

What significant milestones has the company Progyny achieved?

Progyny Inc has achieved several significant milestones since its inception. The company has successfully established itself as a leader in fertility benefits management, offering comprehensive solutions to employers and individuals. Progyny Inc has rapidly expanded its network of fertility clinics and providers, ensuring a wide range of options for patients. With a focus on personalized care and cutting-edge technology, Progyny Inc has helped thousands of individuals and couples navigate their fertility journeys. The company's commitment to research and innovations in reproductive medicine has further solidified its position in the industry. Progyny Inc continues to make strides towards revolutionizing fertility care and supporting individuals in building their families.

What is the history and background of the company Progyny?

Progyny Inc. is a prominent fertility benefits management company headquartered in New York. Established in 2015, Progyny offers comprehensive fertility solutions to employers and their employees, aiming to simplify and enhance the fertility journey. With a mission to make advancements in reproductive medicine accessible to a wider population, Progyny combines innovative technology, personalized care, and financial options to cater to diverse fertility needs. This company has successfully partnered with a vast network of world-class fertility specialists and providers to deliver exceptional outcomes. Progyny Inc. continues to play a crucial role in revolutionizing fertility benefits and ensuring that individuals can pursue their dreams of starting a family smoothly.

Who are the main competitors of Progyny in the market?

Progyny Inc faces competition from other companies in the fertility benefits industry such as Carrot, WINFertility, and Future Family. These companies provide similar services and solutions for infertility treatments and family-building support. However, Progyny Inc distinguishes itself by offering a comprehensive and personalized approach to fertility benefits, leveraging data analytics and providing access to a nationwide network of fertility specialists. With its innovative solutions and strategic partnerships, Progyny Inc stands out as a leading player in the market, committed to empowering individuals and couples on their journey to parenthood.

In which industries is Progyny primarily active?

Progyny Inc is primarily active in the healthcare industry.

What is the business model of Progyny?

Progyny Inc. is a leading fertility benefits management company. Their business model revolves around providing comprehensive fertility benefits to individuals and employers. Progyny's services include personalized care coordination, expert medical guidance, and access to a wide network of fertility specialists. By partnering with Progyny, individuals and employers are able to navigate the complex fertility landscape with ease, gaining access to innovative treatments and technologies. With a strong focus on patient outcomes and cost containment, Progyny aims to enhance the fertility journey for all involved parties. Through their unique business model, Progyny strives to empower individuals, improve outcomes, and build a more inclusive future for fertility care.

What is the P/E ratio of Progyny 2025?

The Progyny P/E ratio is 39.45.

What is the P/S ratio of Progyny 2025?

The Progyny P/S ratio is 1.76.

What is the Quality Investing of Progyny?

The Quality Investing for Progyny is 3/10.

What is the revenue of Progyny 2025?

The expected Progyny revenue is 1.18 B USD.

How high is the profit of Progyny 2025?

The expected Progyny profit is 52.62 M USD.

What is the business model of Progyny

Progyny Inc is a leading healthcare company specializing in fertility treatments and services. The company was founded in 2008 and is headquartered in New York City. Progyny offers a comprehensive range of services to its customers, ranging from diagnosis to family support. Progyny provides its customers with personalized fertility programs that consider both medical and psychological aspects. The program begins with a comprehensive diagnosis and counseling to determine where the customer is on the fertility spectrum and what treatment options are available to them. Then, a treatment plan tailored to the specific needs of the customer is created. Progyny works with a range of doctors and clinics to ensure that its customers receive the best available treatment. An important part of Progyny's business model is its fertility network. The company has partnership agreements with over 500 fertility clinics and centers nationwide, producing over 2,000 success stories per year. Thanks to its network, Progyny has the ability to offer its customers comprehensive access to diagnostic and therapeutic services to achieve a successful pregnancy. Progyny also offers an online platform that facilitates customer access to its services. The website and mobile app provide a user-friendly interface for customers to view their lab results and medical records, as well as manage their treatment plans. Additionally, the platform provides a comprehensive collection of resources and information on fertility. Another key component of Progyny's offering is its financing options. Fertility treatments can be expensive, and many insurance plans do not cover them. However, Progyny has developed its own financing tools to help customers bear the costs of treatment. The company offers flexible financing options, discounts for self-pay patients, and a special membership, among other options. Progyny aims to provide a comprehensive suite of services that meet the needs and desires of its customers. The company focuses on delivering cutting-edge technologies to improve the success rate of fertility treatments, as well as an unmatched customer experience. Progyny strives to be a reliable partner for its customers, supporting them at every step of their fertility journey.

What is the Progyny dividend?

Progyny pays a dividend of 0 USD distributed over payouts per year.

How often does Progyny pay dividends?

The dividend cannot currently be calculated for Progyny or the company does not pay out a dividend.

What is the Progyny ISIN?

The ISIN of Progyny is US74340E1038.

What is the Progyny WKN?

The WKN of Progyny is A2PT5Q.

What is the Progyny ticker?

The ticker of Progyny is PGNY.

How much dividend does Progyny pay?

Over the past 12 months, Progyny paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Progyny is expected to pay a dividend of 0 USD.

What is the dividend yield of Progyny?

The current dividend yield of Progyny is .

When does Progyny pay dividends?

Progyny pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Progyny?

Progyny paid dividends every year for the past 0 years.

What is the dividend of Progyny?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Progyny located?

Progyny is assigned to the 'Health' sector.

Wann musste ich die Aktien von Progyny kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Progyny from 1/18/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/18/2025.

When did Progyny pay the last dividend?

The last dividend was paid out on 1/18/2025.

What was the dividend of Progyny in the year 2024?

In the year 2024, Progyny distributed 0 USD as dividends.

In which currency does Progyny pay out the dividend?

The dividends of Progyny are distributed in USD.

All fundamentals about Progyny

Our stock analysis for Progyny Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progyny Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.